Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 2
Submit an article Journal homepage
526
Views
5
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

CD20-positive multiple myeloma: can conventional chemotherapy still be used to achieve ideal outcome for these patients?

Beihui HuangDepartment of Hematology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
,
Juan LiDepartment of Hematology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, ChinaCorrespondence[email protected]
,
Junru LiuDepartment of Hematology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
&
Jingli GuDepartment of Hematology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Pages 335-340 | Received 21 Feb 2015, Accepted 20 May 2015, Published online: 28 Aug 2015

References

  • Li J, Zhao Y, Luo SK, et al. The clinical features, chemotherapy responses and survival of 223 patients with newly diagnosed multiple myeloma. Zhonghua Yi Xue Za Zhi 2008;30:2140–2143.
  • International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003;5:749–757.
  • Goasguen JE, Zandecki M, Mathiot C, et al. Mature plasma cells as indicator of better prognosis in multiple myeloma. New methodology for the assessment of plasma cell morphology. Leuk Res 1999;12: 1133–1140.
  • Blade J, Samson D, Reece D, et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol 1998;5:1115–1123.
  • Lin P, Owens R, Tricot G, et al. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. Am J Clin Pathol 2004;4: 482–488.
  • Zhan F, Barlogie B, Arzoumanian V, et al. Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis. Blood 2007;4:1692–1700.
  • Grigoriadis G, Gilbertson M, Came N, et al. Is CD20 positive plasma cell myeloma a unique clinicopathological entity? A study of 40 cases and review of the literature. Pathology 2012;6:552–556.
  • Heerema-McKenney A, Waldron J, Hughes S, et al. Clinical, immunophenotypic, and genetic characterization of small lymphocyte-like plasma cell myeloma: a potential mimic of mature B-cell lymphoma. Am J Clin Pathol 2010;2:265–270.
  • Robillard N, Avet-Loiseau H, Garand R, et al. CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma. Blood 2003;3:1070–1071.
  • Quinn J, Percy L, Glassford J, et al. CD20-positive multiple myeloma – differential expression of cyclins D1 and D2 suggests a heterogeneous disease. Br J Haematol 2010;1:156–159.
  • San MJF, Gonzalez M, Gascon A, et al. Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease. Castellano-Leones (Spain) Cooperative Group for the Study of Monoclonal Gammopathies. Br J Haematol 1991;2:185–190.
  • Ruiz-Arguelles GJ, San MJF. Cell surface markers in multiple myeloma. Mayo Clin Proc 1994;7:684–690.
  • Sakalova A, Holomanova D, Mikulecky M, et al. Prognostic value of plasma-cell immunophenotype in patients with multiple myeloma. Neoplasma 1993;6:351–354.
  • San MJF, Garcia-Sanz R, Gonzalez M, et al. Immunophenotype and DNA cell content in multiple myeloma. Baillieres Clin Haematol 1995;4:735–759.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.